PolyPid
Price & Volume
Stats
See more52W Range | $2.44-$5.12 |
Market Cap | $82.2M |
Shares Short | 44,212 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.09 |
News
See moreYahoo Finance • 4 months ago
PolyPid Announces Positive FDA Pre-NDA Meeting Minutes for D-PLEX₁₀₀ Supporting NDA Submission
Yahoo Finance • 5 months ago
PolyPid Provides Corporate Update and Reports Third Quarter 2025 Financial Results
Yahoo Finance • 5 months ago
PolyPid's D-PLEX₁₀₀ Wins BioTech Breakthrough Award for "Therapeutics Solution of the Year"
Yahoo Finance • 5 months ago
PolyPid to Report Third Quarter 2025 Financial Results and Operational Highlights on November 12, 2025
About
CEO | Ms. Dikla Czaczkes Akselbrad |
Address | 18 Hasivim Street, Petah Tikva, Israel, 4959376 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 69 |
